Race as a variable in pharmacogenomics science: From empirical ethics to publication standards

Pharmacogenetics and Genomics

Volumn 18, Issue 10, 2008, Pages 837-841

  Ozdemir, Vural ^a,c   Graham, Janice E ^b   Godard, Béatrice ^a  

^a Faculty of Medicine   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c University Faculty of Medicine   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HUMAN; MEDICAL ETHICS; MEDICAL RESEARCH; PHARMACOGENOMICS; PRIORITY JOURNAL; PUBLICATION; RACE; RACE DIFFERENCE; SOCIOLOGY;

CONTINENTAL POPULATION GROUPS; EMPIRICAL RESEARCH; HUMANS; PHARMACOGENETICS; PUBLISHING; SOCIAL SCIENCES; TERMINOLOGY AS TOPIC;

EID: 53549095688     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e32830a48f3     Document Type: Editorial

References (40)

1. Suarez-Kurtz G. The implications of population admixture in race-based drug prescription. Clin Pharmacol Ther 2008; 83:399-400.
2. Egalite N, Ozdemir V, Godard B. Pharmacogenomics research involving racial classification: qualitative research findings on researchers' views, perceptions and attitudes towards socio-ethical responsibilities. Pharmacogenomics 2007; 8:1115-1126.
3. Bates BR, Poirot K, Harris TM, Condit CM, Achter PJ. Evaluating directto-consumer marketing of race-based pharmacogenomics: a focus group study of public understandings of applied genomic medication. J Health Commun 2004; 9:541-559.
4. Bhopal R, Donaldson L White, European, Western, Caucasian, or what? Inappropriate labeling in research on race, ethnicity, and health. Am J Public Health 1998; 88:1303-1307.
5. Fullilove MT. Comment: abandoning 'race' as a variable in public health research-an idea whose time has come. Am J Public Health 1998; 88:1297-1298.
6. Lieberman L, Stevenson BW, Reynolds LT. Race and anthropology: core concept without consensus. Anthropol Educ Q 1989; 20:67-73.
7. Goodman AH. Why genes don't count (for racial differences in health). Am J Public Health 2000; 90:1699-1702.
8. Ozdemir V, Godard B. Evidence based management of nutrigenomics expectations and ELSIs. Pharmacogenomics 2007; 8:1051-1062.
9. Kalow W. Life of a pharmacologist or the rich life of a poor metabolizer. Pharmacol Toxicol 1995; 76:221-227.
10. Roots I, Gerloff T, Meisel C, Kirchheiner J, Goldammer M, Kaiser R, et al. Pharmacogenetics-based new therapeutic concepts. Drug Metab Rev 2004; 36:617-638.
11. Gurwitz D, Motulsky AG. 'Drug reactions, enzymes, and biochemical genetics': 50 years later. Pharmacogenomics 2007; 8:1479-1484.
12. Desta Z, Zhao X, Shin JG, Flockhart DA. Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin Pharmacokinet 2002; 41:913-958.
13. Bloche MG. Race-based therapeutics. N Engl J Med 2004; 351:2035-2037.
14. Nguyen A, Desta Z, Rockhart DA. Enhancing race-based prescribing precision with pharmacogenomics. Clin Pharmacol Ther 2007; 81: 323-325.
15. Braun L, Fausto-Sterling A, Fullwiley D, Hammonds EM, Nelson A, Quivers W, et al. Racial categories in medical practice: how useful are they? PLoS Med 2007; 4:e271.
16. Epstein S. Bodily differences and collective identities: the politics of gender and race in biomedical research in the United States. Body Soc 2004; 10:183-203.
17. Lee SS-J. The ethical implications of stratifying by race in pharmacogenomics. Clin Pharmacol Ther 2007; 81:122-125.
18. US Office of Management and Budget. Available at: http://www.whitehouse. gov/omb/inforeg/r & e_app-a-update.pdf. Accessed on May 20, 2008.
19. Suarez-Kurtz G, Pena SD. Pharmacogenomics in the Americas: the impact of genetic admixture. Curr Drug Targets 2006; 7:1649-1658.
20. Race, Ethnicity, and Genetics Working Group of the National Human Genome Research Institute (Bethesda). The use of racial, ethnic, and ancestral categories in human genetics research. Am J Human Genet 2005; 77:519-532.
21. Bhopal R. Spectre of racism in health and health care; lessons from history and the United States. Br Med J 1998; 316:1970-1973.
22. Kahn J. Race, pharmacogenomics, and marketing: putting BiDil in context. Am J Bioethics 2006; 6:W1-W5.
23. Olivier C, Williams-Jones B, Godard B, Mikalson B, Ozdemir V. Personalized medicine, bioethics and social responsibilities: Re-thinking the pharmaceutical industry to remedy inequities in patient care and international health. Curr Pharmacogenom Pers Med 2008; 6:108-120. Available online for open access at: http://www.bentham-direct.org/pages/content.php?CPPM/ 2008/00000006/00000002/004AF.SGM. Accessed on June 16, 2008.
24. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication. Philadelphia (PA): ICJME. Available at www.icmje.org. Accessed on May 21, 2008.
25. Anonymous. The unexamined population. Nat Genet 2004; 36 (11 Suppl):S3.
26. Smart A, Tutton R, Ashcroft R, Martin PA, Ellison GTH. Can science alone improve the measurement and communication of race and ethnicity in genetic research? Exploring the strategies proposed by Nature Genetics. BioSocieties 2006; 1:313-324.
27. Montoya MJ. Bioethnic conscription: genes, race, and Mexicana/o ethnicity in diabetes research. Cult Anthropol 2007; 22:94-128.
28. Ellison GTH, Smart A, Tutton R, Outram SM, Ashcroft R, Martin P. Racial categories in medicine: a failure of evidence-based practice? PLoS Med 2007; 4:1434-1436.
29. Brown M; The PLoS Medicine editors. Defining human differences in biomedicine. PLoS Med 2007; 4:e288.
30. The Belmont Report. Ethical Principles and Guidelines for the Protection of Human Subjects of Research, DHEW Publication No. (OS) 78-0012 (1978).
31. Beauchamp T, Childress J. Principles of biomedical ethics. New York: Oxford University Press; 1994.
32. Hedgecoe AM. Critical bioethics: beyond the social science critique of applied ethics. Bioethics 2004; 18:120-143.
33. Denzin NK, Lincoln YS. The SAGE handbook of qualitative research. 3rd ed. Thousand Oaks, CA: Sage Publications; 2005. pp. 1-1232.
34. Cooper RJ, Bissell P, Wingfield J. A new prescription for empirical ethics research in pharmacy: a critical review of the literature. J Med Ethics 2007; 33:82-86.
35. O'Malley MA, Dupré J. Fundamental issues in systems biology. Bioessays 2005; 27:1270-1276.
36. O'Malley MA, Calvert J, Dupré J. The study of socioethical issues in systems biology. Am J Bioethics 2007; 7:67-78.
37. Powell A, O'Malley MA, Müller-Wille S, Calvert J, Dupré J. Disciplinary baptisms: a comparison of the naming stories of genetics, molecular biology, genomics, and systems biology. Hist Philos Life Sci 2007; 29: 5-32.
38. McNally R, Glasner P. Transcending the genome? Studying life in the proteomic bioscape. In: Glasner P, Atkinson P, Greenslade H, editors. New genetics, new social formations. London: Routledge; 2006.
39. Rose N, Rabinow P. Introduction. In: Rose N, Rabinow P, editors. The Essential Foucault: Selections from Essential Works of Foucault, 1954-1984. New York: New Press; 2003.
40. Ozdemir V, Godard B. Crossing the blood-brain-barrier: Integration of scientific innovation with socio-ethical reflection. Psychiatric Times 2007; 24:1-3. Available at: http://www.psychiatrictimes.com/display/article/ 10168/54296. Accessed May 20, 2008.